[HTML][HTML] Lung cancer and interstitial lung disease: a literature review

JM Naccache, Q Gibiot, I Monnet… - Journal of thoracic …, 2018 - ncbi.nlm.nih.gov
The association between lung cancer (LC) and interstitial lung disease (ILD) can be
explained by the shared risk factors like smoking and physiopathology of fibrogenesis and …

Comorbidities in the management of patients with lung cancer

C Leduc, D Antoni, A Charloux… - European Respiratory …, 2017 - Eur Respiratory Soc
Lung cancer represents a major public health issue worldwide. Unfortunately, more than half
of them are diagnosed at an advanced stage. Moreover, even if diagnosed early, diagnosis …

Japanese guideline for the treatment of idiopathic pulmonary fibrosis

S Homma, M Bando, A Azuma, S Sakamoto… - Respiratory …, 2018 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is a disease of unknown etiology which accounts for a
large proportion of cases of idiopathic interstitial pneumonia. It has a very poor prognosis …

Phase II study of nab‐paclitaxel+ carboplatin for patients with non‐small‐cell lung cancer and interstitial lung disease

H Kenmotsu, K Yoh, K Mori, A Ono, T Baba… - Cancer …, 2019 - Wiley Online Library
The prognosis of non‐small‐cell lung cancer (NSCLC) patients with interstitial lung disease
(ILD) is poor, and 5%‐20% of those receiving chemotherapy experience ILD exacerbation …

Lung cancer in patients with fibrosing interstitial lung diseases: an overview of current knowledge and challenges

N Kewalramani, C Machahua, V Poletti… - ERJ open …, 2022 - Eur Respiratory Soc
Patients with progressive fibrosing interstitial lung diseases (fILD) have increased morbidity
and mortality. Lung fibrosis can be associated with lung cancer. The pathogenesis of both …

Effect of platinum-based chemotherapy for non-small cell lung cancer patients with interstitial lung disease

H Kenmotsu, T Naito, K Mori, R Ko, A Ono… - Cancer chemotherapy …, 2015 - Springer
Purpose The prognosis of non-small cell lung cancer (NSCLC) patients with interstitial lung
disease (ILD) is unclear. To assess the prognosis of NSCLC patients with ILD treated with …

French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis-2017 update. Full-length version

V Cottin, B Crestani, J Cadranel… - Revue des …, 2017 - pubmed.ncbi.nlm.nih.gov
French practical guidelines for the diagnosis and management of idiopathic pulmonary
fibrosis - 2017 update. Full-length version French practical guidelines for the diagnosis and …

[HTML][HTML] Acute exacerbation of idiopathic interstitial pneumonias related to chemotherapy for lung cancer: nationwide surveillance in Japan

Y Minegishi, A Gemma, S Homma, K Kishi… - ERJ Open …, 2020 - Eur Respiratory Soc
Background Chemotherapy-induced acute exacerbation (AEx) of idiopathic interstitial
pneumonias (IIPs) seriously compromises the success of treatment of Japanese lung cancer …

[HTML][HTML] Interstitial lung disease associated with lung cancer: a case–control study

Q Gibiot, I Monnet, P Levy, AL Brun, M Antoine… - Journal of clinical …, 2020 - mdpi.com
Interstitial lung disease (ILD) seems to be associated with an increased risk of lung cancer
(LC) and to have a poorer prognosis than LC without ILD. The frequency of ILD in an LC …

Second-line docetaxel for patients with platinum-refractory advanced non-small cell lung cancer and interstitial pneumonia

N Watanabe, S Niho, K Kirita, S Umemura… - Cancer chemotherapy …, 2015 - Springer
Purpose The role of second-line chemotherapy in patients with non-small cell lung cancer
(NSCLC) and preexisting interstitial pneumonia (IP) previously treated with platinum-based …